Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detection
-
Add time:07/16/2019 Source:sciencedirect.com
Delavirdine is a newly developed anti-HIV-1 drug for AIDS therapy. This study describes a sensitive high-performance liquid chromatographic method for the determination of delavirdine in 50 μl of plasma. Samples were deproteinized with 150 μl of a solution of internal standard (cisapride 10 μg/ml) in acetonitrile. An aliquot of the supernatant was injected onto the column. HPLC separation was achieved on a C18 column with the mobile phase of acetonitrile-50 mM sodium dihydrogen phosphate (60:40, v/v) at a flow-rate of 1 ml/min. The eluants were measured by fluorescence detection with excitation at 295 nm and emission filtration at 425 nm. The retention time was about 5.3 min for delavirdine and 6.5 min for cisapride. The specificity was demonstrated, as there were no interferences from plasma samples of different batches in the regions of peak interest. Calibration curves were linear from 25 to 25000 ng/ml. The limit of quantitation was 25 ng/ml. The within- and between-day precision (C.V.) was 9.3%, or less, and the accuracy was within 9.2% of the nominal concentration. The small sample volume needed is especially advantageous for the application both in pharmacokinetic studies in HIV-infected adults and pediatric patients, and in small animals, where limited samples are available.
We also recommend Trading Suppliers and Manufacturers of DELAVIRDINE, MESYLATE (cas 147221-93-0). Pls Click Website Link as below: cas 147221-93-0 suppliers
Prev:Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients
Next:Synthesis of an Anti-AIDs Drug Delavirdine Derivate, Resdelasu) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection07/21/2019
- Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial07/19/2019
- In vitro protein-binding characteristics of delavirdine and its N-dealkylated metabolite07/18/2019
- Synthesis of an Anti-AIDs Drug Delavirdine Derivate, Resdelasu07/17/2019
- Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients07/15/2019
- Factor analysis of infrared spectra for solid-state forms of delavirdine mesylate07/14/2019
- Solid Phases of Delavirdine Mesylate07/13/2019


